Shlomit Kfir‐Erenfeld

892 citations

21 papers · 577 indexed · h-index 12

Co-authors: Eitan Yefenof Ronit Vogt Sionov Rachel Spokoini S. Doron Rifaat Safadi Chamutal Gur Ofer Mandelboim E. Philip Horwitz
Topics: CAR-T cell therapy research (6 papers)Multiple Myeloma Research and Treatments (4 papers)Immune Cell Function and Interaction (3 papers)
Cited by: Immunology Physiology Hepatology
Journals: Journal of Clinical Investigation Blood Gut
Partner nations: Israel Germany United States

In The Last Decade

Shlomit Kfir‐Erenfeld

20 papers receiving 572 citations

Peers

Countries citing papers authored by Shlomit Kfir‐Erenfeld

Since Specialization

Citations

This map shows the geographic impact of Shlomit Kfir‐Erenfeld's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shlomit Kfir‐Erenfeld with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shlomit Kfir‐Erenfeld more than expected).

Fields of papers citing papers by Shlomit Kfir‐Erenfeld

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shlomit Kfir‐Erenfeld. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shlomit Kfir‐Erenfeld. The network helps show where Shlomit Kfir‐Erenfeld may publish in the future.

Co-authorship network of co-authors of Shlomit Kfir‐Erenfeld

This figure shows the co-authorship network connecting the top 25 collaborators of Shlomit Kfir‐Erenfeld. A scholar is included among the top collaborators of Shlomit Kfir‐Erenfeld based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shlomit Kfir‐Erenfeld. Shlomit Kfir‐Erenfeld is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	High Rate of Cytokine Release Syndrome-Related Coagulopathy with Low Incidence of Bleeding and Thrombosis in Patients Treated with B-Cell Maturation Antigen (BCMA)-Targeted Chimeric Antigen Receptor T-Cells (CAR-T) 2025 ·Cancers ·Ariela Arad,Maya Katz,(unknown),Yosef Kalish,Miri Assayag,Batia Avni,Shlomo Elias,Sigal Grisariu,Ela Shai,Shlomit Kfir‐Erenfeld,(unknown),Moshe E. Gatt,Polina Stepensky,Eran Zimran	0
2	Combined Immunodeficiency Caused by a Novel Nonsense Mutation in LCK 2023 ·Journal of Clinical Immunology ·Baerbel Keller,Shlomit Kfir‐Erenfeld,(unknown),Frederike A. Hartl,Atar Lev,Yu Nee Lee,Anthony Simon,Tali Stauber,Orly Elpeleg,Raz Somech,Polina Stepensky,Susana Minguet,Burkhart Schraven,Klaus Warnatz	4
3	Clonal Myeloid Dysplasia Following CAR T-Cell Therapy: Chicken or the Egg? 2023 ·Cancers ·Vladimir Vainstein,Batia Avni,Sigal Grisariu,Shlomit Kfir‐Erenfeld,(unknown),Boaz Nachmias,(unknown),(unknown),Eran Zimran,Miri Assayag,Kalman Filanovsky,Netanel A. Horowitz,(unknown),Adir Shaulov,Michal Gur,Chaggai Rosenbluh,Svetlana Krichevsky,Polina Stepensky,Moshe E. Gatt	8
4	Safety and Efficacy of a Locally Produced Novel Anti-BCMA Chimeric Antigen Receptor T-Cell (CART) (HBI0101) for the Treatment of Relapsed and Refractory Multiple Myeloma 2023 ·Blood ·(unknown),(unknown),Shlomit Kfir‐Erenfeld,Batia Avni,Sigal Grisariu,Shlomo Elias,Miri Assayag,Tatyana Dubnikov,(unknown),Marjorie Pick,Eran Zimran,Yaël C. Cohen,(unknown),Cyrille J. Cohen,Moshe E. Gatt,Polina Stepensky	1
5	Early lymphocyte collection for anti‐CD19 CART production improves T‐cell fitness in patients with relapsed/refractory diffuse large B‐cell lymphoma 2023 ·British Journal of Haematology ·(unknown),Miri Assayag,Batia Avni,Shlomit Kfir‐Erenfeld,(unknown),Moshe E. Gatt,Neta Goldschmidt,Polina Stepensky,(unknown),Sigal Grisariu	15
6	Feasibility of a Novel Academic Anti-BCMA Chimeric Antigen Receptor T-Cell (CART) (HBI0101) for the Treatment of Relapsed and Refractory AL Amyloidosis 2023 ·Blood ·(unknown),Shlomit Kfir‐Erenfeld,(unknown),Sigal Grisariu,Batia Avni,Shlomo Elias,Miri Assayag,Tatyana Dubnikov,(unknown),Marjorie Pick,Eran Zimran,Yaël C. Cohen,(unknown),Cyrille J. Cohen,Polina Stepensky,Moshe E. Gatt	8
7	Feasibility of a Novel Academic BCMA-CART (HBI0101) for the Treatment of Relapsed and Refractory AL Amyloidosis 2022 ·Clinical Cancer Research ·Shlomit Kfir‐Erenfeld,(unknown),Sigal Grisariu,Batia Avni,Eran Zimran,Miri Assayag,(unknown),Marjorie Pick,(unknown),Adir Shaulov,Yaël C. Cohen,Irit Avivi,Cyrille J. Cohen,Polina Stepensky,Moshe E. Gatt	21
8	Development and manufacture of novel locally produced anti-BCMA CAR T cells for the treatment of relapsed/refractory multiple myeloma: results from a phase I clinical trial 2022 ·Haematologica ·(unknown),Shlomit Kfir‐Erenfeld,Batia Avni,Miri Assayag,Tatyana Dubnikov,(unknown),(unknown),Eran Zimran,Adir Shaulov,Marjorie Pick,Yaël C. Cohen,Irit Avivi,Cyrille J. Cohen,Moshe E. Gatt,Sigal Grisariu,Polina Stepensky	17
9	Preclinical evaluation and structural optimization of anti-BCMA CAR to target multiple myeloma 2022 ·Haematologica ·(unknown),(unknown),Shlomit Kfir‐Erenfeld,(unknown),Tilda Barliya,Miri Assayag,Moshe E. Gatt,Polina Stepensky,Cyrille J. Cohen	12
10	Nociception and pain in humans lacking a functional TRPV1 channel 2022 ·Journal of Clinical Investigation ·Ben Katz,(unknown),Simon Edvardson,Channa Maayan,Orly Elpeleg,Shaya Lev,Elyad Davidson,Maximilian Peters,Shlomit Kfir‐Erenfeld,Esther Berger,(unknown),Alexander M. Binshtok,Baruch Minke	41
11	A human case of GIMAP6 deficiency: a novel primary immune deficiency 2020 ·European Journal of Human Genetics ·Bella Shadur,(unknown),Shlomit Kfir‐Erenfeld,(unknown),Adeeb NaserEddin,Yael Dinur Schejter,Orly Elpeleg,Hagar Mor‐Shaked,Polina Stepensky	7
12	Extending the Clinical Phenotype of Adenosine Deaminase 2 Deficiency 2016 ·The Journal of Pediatrics ·Tal Ben‐Ami,Shoshana Revel‐Vilk,Rebecca Brooks,Avraham Shaag,Michael S. Hershfield,Susan J. Kelly,Nancy J. Ganson,Shlomit Kfir‐Erenfeld,Michael Weintraub,Orly Elpeleg,Yackov Berkun,Polina Stepensky	64
13	miR-103 inhibits proliferation and sensitizes hemopoietic tumor cells for glucocorticoid-induced apoptosis 2016 ·Oncotarget ·Shlomit Kfir‐Erenfeld,(unknown),Moshe Biton,Polina Stepensky,(unknown),Eitan Yefenof	29
14	Nitric oxide and glucocorticoids synergize in inducing apoptosis of CD4+8+ thymocytes: implications for ‘Death by Neglect’ and T-cell function 2012 ·International Immunology ·(unknown),Eliran Ish‐Shalom,Shlomit Kfir‐Erenfeld,Ingrid Herr,Eitan Yefenof	5
15	A Role for Bcl-2 in Notch1-Dependent Transcription in Thymic Lymphoma Cells 2012 ·Advances in Hematology ·Ronit Vogt Sionov,Shlomit Kfir‐Erenfeld,Rachel Spokoini,Eitan Yefenof	9
16	NKp46-mediated killing of human and mouse hepatic stellate cells attenuates liver fibrosis 2011 ·Gut ·Chamutal Gur,S. Doron,Shlomit Kfir‐Erenfeld,E. Philip Horwitz,(unknown),Rifaat Safadi,Ofer Mandelboim	137
17	Protein kinase networks regulating glucocorticoid-induced apoptosis of hematopoietic cancer cells: fundamental aspects and practical considerations 2010 ·Leukemia & lymphoma ·Shlomit Kfir‐Erenfeld,Ronit Vogt Sionov,Rachel Spokoini,(unknown),Eitan Yefenof	46
18	Glycogen Synthase Kinase-3 Plays a Central Role in Mediating Glucocorticoid-Induced Apoptosis 2010 ·Molecular Endocrinology ·Rachel Spokoini,Shlomit Kfir‐Erenfeld,Eitan Yefenof,Ronit Vogt Sionov	63
19	Nitric oxide cooperates with glucocorticoids in thymic epithelial cell-mediated apoptosis of double positive thymocytes 2009 ·International Immunology ·(unknown),Shlomit Kfir‐Erenfeld,Rachel Spokoini,Yael Zilberman,Eitan Yefenof,Ronit Vogt Sionov	9
20	Chapter 6 Mechanisms Regulating the Susceptibility of Hematopoietic Malignancies to Glucocorticoid‐Induced Apoptosis 2008 ·Advances in cancer research ·Ronit Vogt Sionov,Rachel Spokoini,Shlomit Kfir‐Erenfeld,(unknown),Eitan Yefenof	63

About Shlomit Kfir‐Erenfeld

Shlomit Kfir‐Erenfeld is a scholar working on Hematology, Immunology and Behavioral Neuroscience, having authored 21 papers that have together received 577 indexed citations. Recurring topics across this work include CAR-T cell therapy research (6 papers), Multiple Myeloma Research and Treatments (4 papers) and Immune Cell Function and Interaction (3 papers). The work is most often cited by research in Immunology (186 citations), Physiology (39 citations) and Hepatology (60 citations). Shlomit Kfir‐Erenfeld has collaborated with scholars based in Israel, Germany and United States. Frequent co-authors include Eitan Yefenof, Ronit Vogt Sionov, Rachel Spokoini, S. Doron, Rifaat Safadi, Chamutal Gur, Ofer Mandelboim, E. Philip Horwitz, Polina Stepensky and Orly Elpeleg. Their work appears in journals such as Journal of Clinical Investigation, Blood and Gut.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact